Gossamer Bio (GOSS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

GOSS is expected to report earnings to fall 186.36% to -18 cents per share on November 12

Gossamer Bio GOSS Stock Earnings Reports

Q3'24

Est.

$-0.19

Q2'24

Missed

by $0.29

Q1'24

Est.

$-0.19

Q4'23

Est.

$-0.21

Q3'23

Beat

by $0.05

The last earnings report on August 12 showed earnings per share of 21 cents, missing the estimate of 50 cents. With 871.91K shares outstanding, the current market capitalization sits at 217.18M.

View a ticker or compare two or three

Compare

GOSS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GOSS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3013 Science Park Road

Phone

+1 858 684-1300

Employees

135

Web

https://www.gossamerbio.com